Incidence Of HCC May Be Reduced In Patients With Chronic Hepatitis C Genotype 4 With Liver Cirrhosis And Advanced Hepatic Fibrosis Who Achieve Sustained Virologic Response After DAA Treatment, Study Indicates

April 09, 2020

Infectious Disease Advisor (4/8, Schad) reports researchers found in a prospective observational cohort study that “the incidence of hepatocellular carcinoma (HCC) is reduced in patients with chronic hepatitis C genotype 4 with liver cirrhosis and advance...